Tag Archives: BlueRock Therapeutics

BlueRock Therapeutics and bit.bio Collaborate on iPSC-Derived T Cell Therapies for Autoimmune Disorders

Posted on 4, August 2023 by

(IN BRIEF) BlueRock Therapeutics and bit.bio have announced a collaboration and option agreement to discover and manufacture iPSC-derived regulatory T cells (Tregs) for therapeutic use. Tregs are crucial for immune system balance and controlling excessive immune reactions, making them potential … Read the full press release →

Posted in Business, Education, Germany, Healthcare, Management, News, Pharma & Biotech, Science

Tagged , , , , , , , , , ,